Cambridge Trust’s Labcorp LH Stock Holding History

Cambridge Trust’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-55	Closed	-$12K	–	907
2022 Q1	$12K	Sell	55 -208	-79%	-$48.9K	﹤0.01%	730
2021 Q4	$71K	Buy	+263	New	+$65.1K	﹤0.01%	477

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Cambridge Trust's LH Position: Q2 2022 in Review

Cambridge Trust sold out of Labcorp (LH) in Q2 2022, closing a stake of 55 shares — an estimated $12K sold.

Cambridge Trust first reported a position in LH in Q4 2021 and held it in 2 quarters. The position peaked at $71K in Q4 2021. 966 funds tracked by Wall St. Rank hold LH as of Q2 2022.

Cambridge Trust reported no remaining Labcorp position as of Q2 2022 after selling out during the quarter.
Cambridge Trust sold 55 Labcorp shares in Q2 2022, an estimated $12K.
Cambridge Trust first reported a position in Labcorp in Q4 2021 and held it in 2 quarters.
Cambridge Trust's Labcorp position peaked at $71K in Q4 2021.
966 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on Cambridge Trust's 13F filing for Q2 2022, filed 16 Aug 2022.